Hubei Longxiang Pharmaceuticals, China, 2022
GMP Audit Report
Company
Hubei Longxiang Pharmaceuticals
Product(s)
Tilmicosin
Country
China
Audit Year
2022
This product is no longer available.
Company
Hubei Longxiang Pharmaceuticals
Product(s)
Tilmicosin
Country
China
Audit Year
2022
This product is no longer available.